Literature DB >> 29785288

T1a lung carcinoma: the place of segmentectomy in the treatment array.

Sameer A Hirji1, Scott J Swanson1.   

Abstract

Contemporary management of early stage non-small cell lung cancer (NSCLC) is evolving and can be attributed to a change in size and histology of lung cancer, advancements in imaging modalities, instrumentation and surgical techniques. The emergence of segmentectomy has further challenged the existing treatment landscape, with promising results. Despite limited widespread adoption, video-assisted thoracoscopic surgery (VATS) segmentectomy is a safe option in the treatment of patients with small stage I lung cancers, with excellent oncologic results and improved morbidity relative to open techniques. In this paper, we critically examine the utility of segmentectomy, and the emerging role of VATS, including technical tips and tricks, in the management of T1a lung carcinoma.

Entities:  

Keywords:  Segmentectomy; thoracoscopy/video-assisted thoracoscopic surgery (VATS)

Year:  2018        PMID: 29785288      PMCID: PMC5949388          DOI: 10.21037/jtd.2018.01.33

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  30 in total

1.  Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

2.  Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.

Authors:  Matthew J Schuchert; Brian L Pettiford; Samuel Keeley; Thomas A D'Amato; Arman Kilic; John Close; Arjun Pennathur; Ricardo Santos; Hiran C Fernando; James R Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

3.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

4.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

5.  Segmentectomy and Lung Cancer: Why, When, How, and How Good?

Authors:  Rodney J Landreneau; Thomas A D'Amico; Matt J Schuchert; Scott J Swanson
Journal:  Semin Thorac Cardiovasc Surg       Date:  2017-04-06

6.  A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.

Authors:  Chi-Fu Jeffrey Yang; Arvind Kumar; Jacob A Klapper; Matthew G Hartwig; Betty C Tong; David H Harpole; Mark F Berry; Thomas A D'Amico
Journal:  Ann Surg       Date:  2019-01       Impact factor: 12.969

7.  Open, thoracoscopic and robotic segmentectomy for lung cancer.

Authors:  Chi-Fu Jeffrey Yang; Thomas A D'Amico
Journal:  Ann Cardiothorac Surg       Date:  2014-03

Review 8.  Segmental resection spares pulmonary function in patients with stage I lung cancer.

Authors:  Robert J Keenan; Rodney J Landreneau; Richard H Maley; Deepak Singh; Robin Macherey; Susan Bartley; Tibetha Santucci
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

9.  Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.

Authors:  Rajwanth R Veluswamy; Nicole Ezer; Grace Mhango; Emily Goodman; Marcelo Bonomi; Alfred I Neugut; Scott Swanson; Charles A Powell; Mary B Beasley; Juan P Wisnivesky
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

10.  Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancer.

Authors:  Ryan A Macke; Matthew J Schuchert; David D Odell; David O Wilson; James D Luketich; Rodney J Landreneau
Journal:  J Cardiothorac Surg       Date:  2015-04-01       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.